The document provides an overview of the pharmaceutical market in China based on a market research report by Beijing Zeefer Consulting Ltd. It discusses the size and growth of the overall pharmaceutical market as well as key sub-markets like prepared medicines, raw materials, and medical supplies. It also analyzes the market position of foreign companies, industry size metrics, import/export trends, and the competitive landscape of leading companies.

2. PHARMACEUTICALS
MARKET IN CHINA
Market Brief
Beijing Zeefer Consulting Ltd.
October 2011

3. Authorized by:
Beijing Zeefer Consulting Ltd.
Company Site:
http://www.Zeefer.org
Online Store of China Industry Reports:
http://www.AllChinaReports.com
Beijing Zeefer Consulting Ltd. and (or) its affiliates (hereafter,
"Zeefer") provide this publication with the greatest possible care.
Nevertheless, Zeefer makes no guarantee whatsoever regarding the
accuracy, utility, or certainty of the information in this publication.
Further, Zeefer disclaims any and all responsibility for damages that
may result from the use or non-use of the information in this
publication.
The information in this publication may be incomplete and/or may
differ in expression from other information in elsewhere by other
means. The information contained in this publication may also be
changed or removed without prior notice.

4. About Zeefer Consulting
Beijing Zeefer Consulting Ltd. is a professional consulting firm focusing on providing China
market research, China market entry strategy and industrial intelligence information services.
ZEEFER was founded in 2002, located in Beijing, China.
ZEEFER’s research service includes:
CHINA MARKET ENTRY RESEARCH
It is market entry guidance for target products, providing essential China market information,
assisting clients to enter China market and expand market share in China. This research
service extensively covers main industry products and consumer products.
CUSTOMIZED MARKET RESEARCH
Providing on demand market research service, it is focusing on assisting clients to solve the
individual issues when they are interested in China market. Usually the research contents
covering product viability, competition analysis, market size, sales channel, administration
issues, market trends, industry policies, market entry issues, etc.
CHINA IMPORTED AND EXPORTED COMMODITIES RESEARCH
Providing import and export data analysis for target products, a direct view to describe import
and export trend by plenty figures and tables. Contrasting the trade data in different countries,
origins, destinations and trade modes. To discover the fact and reason behind the trend
changes.
FINDING CHINESE PARTNERS
To assist clients in finding the right potential partners, connecting clients with potential buyers,
distributors, agents, importers and exporters, administrative organizations and competitors in
China.
CHINA INDUSTRY PROFILES
500+ yearly updated industry profiles on 500+ Chinese industries. The profiles present
overview for each of these industries by providing concise analyses and 3 years key data.
These profiles reflect the position of foreign enterprises and show the regional differences
across China in each of the industries.
CHINA MARKET REPORTS
This series includes more than 200 market research reports on over 200 market sectors in
China. Contents of these reports consist of market size, market share & structure, hot
domestic regions, top 10 enterprises, import & export, key statistical data and industry
standards. All the market reports are yearly updated.
For more information please visit:
Company Site: www.Zeefer.org
China Industry Reports: www.AllChinaReports.com

5. TABLE OF CONTENT
Pharmaceutical & Medicine Market in China....................................................................1
Chinese Prepared Medicines Market in China ...................................................................4
Pharmaceutical Raw Materials Market in China...............................................................7
Medical Materials & Supplies Market in China...............................................................10

6. www.AllChinaReports.com
Industry Reports & Market Research
PHARMACEUTICAL & MEDICINE MARKET
IN CHINA
China pharmaceutical & medicine market size exceeded RMB 250 billion
in 2009, a growth of more than 20% on a year-on-year basis, according to
Zeefer Consulting's research report - China Pharmaceutical & Medicine
Market Report.
In terms of market position of foreign enterprises in China, in 2009, there
were more than 250 foreign enterprises above designated size engaged in
the pharmaceutical & medicine industry, accounting for more than 20% of
all pharmaceutical & medicine enterprises above designated size across
China. All foreign pharmaceutical & medicine enterprises achieved a
profit of more than RMB 10 billion in all, accounting for more than 45% of
the total profit in this industry.
In terms of the industry size, in 2009, enterprises above designated size
inside the pharmaceutical & medicine industry achieved a sales revenue
of more than RMB 200 billion in all. In the pharmaceutical & medicine
industry, more than 1,000 enterprises were above designated size, an
increase of more than 5% on a year-on-year basis. On an annual average,
employees in pharmaceutical & medicine industry were more than
425,000, an increase of more than 4% on a year-on-year basis.
In terms of industry profit, in 2009, enterprises above designated size in
pharmaceutical & medicine industry across China achieved a profit of
more than RMB 25 billion in all, a growth of more than 20% on a
year-on-year basis. In 2009, more than 250 enterprises in this industry
suffered a loss. The industry average of the rate of return on assets was
Beijing Zeefer Consulting Ltd. -1-

7. www.AllChinaReports.com
Industry Reports & Market Research
higher than 10%, and the rate of return on net assets was higher than 15%.
In terms of pharmaceutical & medicine import and export, in 2010, the
value of imported pharmaceutical & medicine products in China was
more than USD 5 billion, and Germany, Italy and USA ranked top 3 as
Origin of Imported Goods, imports from these top three origins added up
to USD 2.1 billion, accounting for more than 35% of the gross imports.
Shanghai, Beijing and Jiangsu ranked top 3 domestic destinations in
imports, and the value of imports in these three regions added up to USD
3.1 billion, accounting for more than 55% of the gross imports across
China. In 2010, the gross export of pharmaceutical & medicine products
exceeded USD 900 million, Jiangsu, Shanghai and Hebei ranked top 3 as
domestic origins, exports from these origins added up to USD 435.2
million, accounting for more than 45% of the gross export across China.
In terms of the market share in China, top 10 leading enterprises in
pharmaceutical & medicine industry won a market share of more than
25% in all in terms of the sales revenue, and the top leading enterprise
gained a market share of more than 7% (source: data for 2008). In terms of
the market position of imported pharmaceutical & medicine products, in
2009, imported products won a market share of higher than 11% in the
pharmaceutical & medicine market across China.
Data Source:
China Pharmaceutical & Medicine Market Report
Related Industry Reports:
China Pharmaceutical Mfg. Industry Profile
China Pharmaceutical & Medicine Mfg. Industry Profile
China Pharmaceuticals Industry Profile
Top Five Companies In Pharmaceutical & Medicine Mfg. Industry In China
Beijing Zeefer Consulting Ltd. -2-

8. www.AllChinaReports.com
Industry Reports & Market Research
中国医薬品製剤製造業界レポート
中国医薬品製造業界レポート
Beijing Zeefer Consulting Ltd. -3-

9. www.AllChinaReports.com
Industry Reports & Market Research
CHINESE PREPARED MEDICINES MARKET
IN CHINA
According to Zeefer Consulting's research report - China Chinese
Prepared Medicines Market Report and calculated according to Zeefer
China Market Size formula, China chinese prepared medicines market
size in 2009 exceeded RMB 150 billion, a growth of more than 20% on a
year-on-year basis.
In terms of market position of foreign enterprises in China, in 2009, there
were more than 200 foreign enterprises above designated size engaged in
the chinese prepared medicines industry, accounting for more than 10%
of all chinese prepared medicines enterprises above designated size
across China. These enterprises achieved a sales revenue of more than
RMB 20 billion in all, accounting for more than 10% of the total sales
revenue from all chinese prepared medicines enterprises above
designated size across China.
In terms of the industry size, in 2009, enterprises above designated size
inside the chinese prepared medicines industry achieved a sales revenue
of more than RMB 150 billion in all. They produced a total of more than
1,445,000 tons of chinese patent medicine, a rise of more than 10% in total
production on a year-on-year basis. The total assets of all enterprises in
the industry exceeded RMB 200 billion, a rise of more than 10% on a
year-on-year basis. On an annual average, employees in chinese prepared
medicines industry were more than 380,000, an increase of more than 5%
on a year-on-year basis.
In terms of industry profit, in 2009, enterprises above designated size in
Beijing Zeefer Consulting Ltd. -4-

10. www.AllChinaReports.com
Industry Reports & Market Research
chinese prepared medicines industry across China achieved a profit of
more than RMB 15 billion in all, a growth of more than 20% on a
year-on-year basis. On average, enterprises achieved a profit margin of
more than 10%. The industry average of the rate of return on assets was
higher than 7%, and the rate of return on net assets was higher than 10%.
In terms of chinese prepared medicines import and export, in 2010, the
value of imported chinese prepared medicines products in China was
more than USD 200 million, and Hong Kong, Germany and Japan ranked
top 3 as Origin of Imported Goods, imports from these top three origins
added up to USD 210.1 million, accounting for more than 95% of the gross
imports. Guangdong, Shanghai and Beijing ranked top 3 domestic
destinations in imports, and the value of imports in these three regions
added up to USD 211.4 million, accounting for more than 95% of the gross
imports across China. In 2010, the gross export of chinese prepared
medicines products exceeded USD 200 million, and Hong Kong, Japan
and India ranked top 3 as export destinations. Exports to these
destinations added up to USD 112.3 million, accounting for more than
40% of the gross export.
In terms of the market share in China, top 10 leading enterprises in
chinese prepared medicines industry won a market share of more than
20% in all in terms of the sales revenue, and the top leading enterprise
gained a market share of more than 5% (source: data for 2008). In terms of
the market position of imported chinese prepared medicines products, in
2009, imported products won a market share of 0.7% in the chinese
prepared medicines market across China.
Data Source:
China Chinese Prepared Medicines Market Report
Beijing Zeefer Consulting Ltd. -5-

11. www.AllChinaReports.com
Industry Reports & Market Research
Related Industry Reports:
China Pharmaceutical Mfg. Industry Profile
China Chinese Prepared Medicines Mfg. Industry Profile
China Pharmaceuticals Industry Profile
中国漢方製剤製造業界レポート
中国医薬品製造業界レポート
Beijing Zeefer Consulting Ltd. -6-

12. www.AllChinaReports.com
Industry Reports & Market Research
PHARMACEUTICAL RAW MATERIALS
MARKET IN CHINA
According to Zeefer Consulting's research report - China Pharmaceutical
Raw Materials Market Report and calculated according to Zeefer China
Market Size formula, China pharmaceutical raw materials market size in
2009 exceeded RMB 150 billion, a growth of more than 15% on a
year-on-year basis.
In terms of market position of foreign enterprises in China, in 2009, there
were more than 200 foreign enterprises above designated size engaged in
the pharmaceutical raw materials industry, accounting for more than 15%
of all pharmaceutical raw materials enterprises above designated size
across China. These enterprises achieved a sales revenue of more than
RMB 45 billion in all, accounting for more than 25% of the total sales
revenue from all pharmaceutical raw materials enterprises above
designated size across China. Foreign pharmaceutical raw materials
enterprises achieved a profit margin of more than 9%, higher than the
industry average, and they achieved a ratio of return on assets of more
than 9%, higher than the industry average.
In terms of the industry size, in 2009, enterprises above designated size
inside the pharmaceutical raw materials industry achieved a sales
revenue of more than RMB 150 billion in all. They produced a total of
more than 1,690,000 tons of pharmaceutical raw materials, almost same in
total production on a year-on-year basis. The total assets of all enterprises
in the industry exceeded RMB 150 billion, a rise of more than 6% on a
year-on-year basis. On an annual average, employees in pharmaceutical
raw materials industry were more than 305,000, an increase of more than
Beijing Zeefer Consulting Ltd. -7-

13. www.AllChinaReports.com
Industry Reports & Market Research
3% on a year-on-year basis.
In terms of industry profit, in 2009, enterprises above designated size in
pharmaceutical raw materials industry across China achieved a profit of
more than RMB 10 billion in all, a growth of more than 10% on a
year-on-year basis. On average, enterprises achieved a profit margin of
more than 8%. In 2009, more than 150 enterprises in this industry suffered
a loss. and the loss from them added up to RMB 804.1 million.
In terms of pharmaceutical raw materials import and export, in 2010, the
value of imported pharmaceutical raw materials products in China was
more than USD 1 billion, and Norway, Ireland and Japan ranked top 3 as
Origin of Imported Goods, imports from these top three origins added up
to USD 711.8 million, accounting for more than 35% of the gross imports.
In 2010, the gross export of pharmaceutical raw materials products
exceeded USD 10 billion, and India, USA and Germany ranked top 3 as
export destinations. Exports to these destinations added up to USD 4.4
billion, accounting for more than 35% of the gross export. Zhejiang,
Jiangsu and Shandong ranked top 3 as domestic origins, exports from
these origins added up to USD 5.5 billion, accounting for more than 45%
of the gross export across China.
In terms of the market share in China, top 10 leading enterprises in
pharmaceutical raw materials industry won a market share of more than
20% in all in terms of the sales revenue, and the top leading enterprise
gained a market share of more than 6% (source: data for 2008). In terms of
the market position of imported pharmaceutical raw materials products,
in 2009, imported products won a market share of less than 8% in the
pharmaceutical raw materials market across China.
Data Source:
Beijing Zeefer Consulting Ltd. -8-

14. www.AllChinaReports.com
Industry Reports & Market Research
China Pharmaceutical Raw Materials Market Report
Related Industry Reports:
China Pharmaceutical Mfg. Industry Profile
China Pharmaceutical Raw Materials Mfg. Industry Profile
China Pharmaceuticals Industry Profile
中国医薬品原薬製造業界レポート
中国医薬品製造業界レポート
Beijing Zeefer Consulting Ltd. -9-

15. www.AllChinaReports.com
Industry Reports & Market Research
MEDICAL MATERIALS & SUPPLIES
MARKET IN CHINA
According to Zeefer Consulting's research report - China Medical
Materials & Supplies Market Report and calculated according to Zeefer
China Market Size formula, China medical materials & supplies market
size in 2009 exceeded RMB 45 billion, a growth of more than 35% on a
year-on-year basis.
In terms of market position of foreign enterprises in China, in 2009, there
were more than 100 foreign enterprises above designated size engaged in
the medical materials & supplies industry, accounting for more than 20%
of all medical materials & supplies enterprises above designated size
across China. These enterprises achieved a sales revenue of more than
RMB 10 billion in all, accounting for more than 20% of the total sales
revenue from all medical materials & supplies enterprises above
designated size across China. Foreign medical materials & supplies
enterprises achieved a profit margin of more than 7%, almost same with
the industry average, and they achieved a ratio of return on assets of more
than 8%, lower than the industry average.
In terms of the industry size, in 2009, enterprises above designated size
inside the medical materials & supplies industry achieved a sales revenue
of more than RMB 45 billion in all. The total assets of all enterprises in the
industry exceeded RMB 35 billion, a rise of more than 30% on a
year-on-year basis. On an annual average, employees in medical materials
& supplies industry were more than 115,000, an increase of more than
10% on a year-on-year basis.
Beijing Zeefer Consulting Ltd. - 10 -

16. www.AllChinaReports.com
Industry Reports & Market Research
In terms of industry profit, in 2009, enterprises above designated size in
medical materials & supplies industry across China achieved a profit of
more than RMB 3 billion in all, a growth of more than 40% on a
year-on-year basis. On average, enterprises achieved a profit margin of
more than 8%. The industry average of the rate of return on assets was
higher than 10%, and the rate of return on net assets was higher than 15%.
In terms of medical materials & supplies import and export, in 2010, the
value of imported medical materials & supplies products in China was
more than USD 600 million, and USA, Netherlands and Japan ranked top
3 as Origin of Imported Goods, imports from these top three origins
added up to USD 317 million, accounting for more than 45% of the gross
imports. In 2010, the gross export of medical materials & supplies
products exceeded USD 1 billion, and USA, Japan and Germany ranked
top 3 as export destinations. Exports to these destinations added up to
USD 585 million, accounting for more than 35% of the gross export.
Jiangsu, Zhejiang and Hubei ranked top 3 as domestic origins, exports
from these origins added up to USD 770.7 million, accounting for more
than 45% of the gross export across China.
In terms of the market share in China, top 10 leading enterprises in
medical materials & supplies industry won a market share of more than
25% in all in terms of the sales revenue, and the top leading enterprise
gained a market share of more than 10% (source: data for 2008). In terms
of the market position of imported medical materials & supplies products,
in 2009, imported products won a market share of less than 7% in the
medical materials & supplies market across China.
Data Source:
China Medical Materials & Supplies Market Report
Beijing Zeefer Consulting Ltd. - 11 -

17. www.AllChinaReports.com
Industry Reports & Market Research
Related Industry Reports:
China Pharmaceutical Mfg. Industry Profile
China Medical Materials & Supplies Mfg. Industry Profile
China Pharmaceuticals Industry Profile
China Other Manufacturing Industry Profile
Top Ten Companies In Medical Materials & Supplies Mfg. Industry In China
中国医療衛生用品製造業界レポート
中国医薬品製造業界レポート
Beijing Zeefer Consulting Ltd. - 12 -

18. Zeefer Publications
China Market Report
Research Reports on Major Industries in China
Publication Date: July 1, 2012
ISBN: 978-0-473-19979-1
Format: Paperback / PDF
Pages: 500+ Paperback / 1200+ PDF
List Price: US$599
The Series Of Approaching China
Publication Date: November 30, 2010
Format: Paperback; List Price: US$129 per title
·Confectionery Market·Beverage Market·Meat Market
·Fruit Industry·Grain & Oil Industries·Dairy Market
·Natural Rubber Market·Apparel Market
·Aquatic Products Market·Medical Industries
China Economy Atlas
Data Maps for 133 Major Chinese Industries
Publication Date: November 20, 2011
ISBN: 978-0-473-19978-4
Format: Paperback / PDF
Pages: 268
List Price: FREE for PDF Version
Get it now!
China Market Brief
Brief Introduction on 193 Market Sectors
Publication Date: November 10, 2011
Format: PDF
Pages: 542
Word Count: 116,126
List Price: FREE
Get it now!